Flash wave light strongly enhanced the cytocidal effect of photodynamic therapy with acridine orange on a mouse osteosarcoma cell line

Anticancer Research

Volumn 27, Issue 5 A, 2007, Pages 3339-3344

  Satonaka, Haruhiko ^a   Kusuzaki, Katsuyuki ^b   Matsubara, Takao ^a   Shintani, Ken ^a   Wakabayashi, Toru ^a   Nakamura, Tomoki ^a   Matsumine, Akihiko ^a   Uchida, Atsumasa ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acridine orange; Flash wave light; Illuminance; Osteosarcoma; Photodynamic therapy

Indexed keywords

ACRIDINE ORANGE; XENON;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENERGY; ILLUMINATION; LIGHT; MOUSE; NONHUMAN; OSTEOSARCOMA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; THERMAL EXPOSURE; TUMOR CELL LINE;

ACRIDINE ORANGE; ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; FLUORESCENT DYES; LIGHT; MICE; OSTEOSARCOMA; PHOTOCHEMOTHERAPY; XENON;

EID: 35348988152     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kusuzaki K, Murata H, Matsubara T, Miyazaki S, Okamura A, Seto M, Matsumine A, Hosoi H, Sugimoto T and Uchida A: Clinical trial of photodynamic therapy using acridine orange with/without low dose radiation as new limb salvage modality in musculoskeletal sarcomas. Anticancer Res 25: 1225-1236, 2005.
2. Kusuzaki K, Murata H, Matsubara T, Miyazaki S, Shintani K, Seto M, Matsumine A, Hosoi H, Sugimoto T and Uchida A: Clinical outcome of a novel photodynamic therapy technique using acridine orange for synovial sarcomas. Photochem Photobiol 81: 705-709, 2005.
3. Yoshida K, Kusuzaki K, Matsubara T, Matsumine A, Kumamoto T, Komada Y, Naka N and Uchida A: Periosteal Ewing's sarcoma treated by photodynamic therapy with acridine orange. Oncol Rep 13: 279-282, 2005.
4. Ueda H, Murata H, Takeshita H, Minami G, Hashiguchi S and Kubo T: Unfiltered xenon light is useful for photodynamic therapy with acridine orange. Anticancer Res 25: 3979-3984, 2005.
5. Asai T, Ueda T, Itoh K, Yoshioka K, Aoki Y, Mori S and Yoshikawa H: Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer 76: 418-422, 1998.
6. Star WM, van't Veen AJ, RobinsonDJ, Munte K, de Haas ER and Sterenborg HJ: Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two-hour interval: long-term follow-up. Acta Derm Venereol 86: 412-417, 2006.
7. Triesscheijn M, Baas P, Schellens JH and Stewart FA: Photodynamic therapy in oncology. Oncologist 11: 1034-1044, 2006.
8. Harty JI, Amin M, Wieman TJ, Tseng MT, Ackerman D and Broqhamer W: Complications of whole bladder dihematoporphyrin ether photodynamic therapy. J Urol 141: 1341-1346, 1989.
9. Manyak MJ and Ogan K: Photodynamic Therapy for Refractory Superficial Bladder Cancer: Long-Term Clinical Outcomes of Single Treatment Using Intravesical Diffusion Medium. J Endourol 17: 633-639, 2003.
10. Keller GS, Doiron DR and Fisher GU: Photodynamic therapy in otolaryngology-head and neck surgery. Arch Otolaryngol 111: 758-761, 1985.
11. Vincent RG, Dougherty TJ, Rao U, Boyle DG and Potter WR: Photoradiation therapy in advanced carcinoma of the trachea and bronchus. Chest 85: 29-33, 1984.
12. McCaughan JS, Hicks W, Laufman L, May E and Roach R: Palliation of esophageal malignancy with photoradiation therapy. Cancer 54: 1905-2910, 1984.
13. Foroulis CN and Thorpe JA: Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer. Eur J Cardiothorac Surg 29: 30-34, 2006.
14. Nanashima A, Yamaguchi H, Shibasaki S, Ide N, Sawai T, Tsuji T, Hidaka S, Sumida Y, Nakagoe T and Nagayasu T: Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study. J Gastroenterol 39: 1095-1101, 2004.
15. Harewood GC, Baron TH, Rumalla A, Wang KK, Gores GJ, Stadheim LM and de Groen PC: Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma. J Gastroenterol Hepatol 20: 415-420, 2005.
16. Taber SW, Fingar VH and Wieman TJ: Photodynamic therapy for palliation of chest wall recurrence in patients with breast cancer. J Surg Oncol 68: 209-214, 1998.
17. Cuenca RE, Allison RR, Sibata C and Downie GH: Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg Oncol 11: 322-327, 2004.
18. Madsen S and Hirschberg H: Photodynamic therapy and detection of high-grade gliomas. J Environ Pathol Toxicol Oncol 25: 453-466, 2006.
19. Stylli SS, Kaye AH, MacGregor L, Howes M and Rajendra P: Photodynamic therapy of high grade glioma - long term survival. J Clin Neurosci 12: 389-398, 2005.
20. Kusuzaki K, Murata H, Takeshita H, Hashiguchi S, Nozaki T, Emoto K, Ashihara T and Hirasawa Y: Intracellular binding sites of acridine orange in living osteosarcoma cells. Anticancer Res 20: 971-976, 2000.
21. Matsubara T, Kusuzaki K, Matsumine A, Shintani K, Satonaka H and Uchida A: Acridine orange used for photodynamic therapy accumulates in malignant musculoskeletal tumors depending on pH gradient. Anticancer Res 26: 187-194, 2006.
22. Kapuscinski J, Darzynkiewicz Z and Melamed MR: Interactions of acridine orange with nucleic acids. Properties of complexes of acridine orange with single stranded ribonucleic acid. Biochem Pharmacol 32: 3679-3694, 1983.
23. Zdolsek JM, Olson M and Brunk UT: Photooxidative damage to lysosomes of cultured macrophages by acridine orange. Photochem Photobiol 51: 67-76, 1990.
24. Zdolsek JM: Acridine orange-mediated photodamage to cultured cells. APMIS 101: 127-132, 1993.
25. Kimura M, Kashikura K, Yokoi S, Koiwa Y, Tokuoka Y and Kawashima N: Photodynamic therapy for cancer cells using a flash wave light xenon lamp. Opt Rev 12: 207-210, 2005.
26. Alexiades-Armenakas M: Laser-mediated photodynamic therapy. Clin Dermatol 24: 16-25, 2006.
27. Kashtan H, Haddad R, Greenberg R, Skornick Y and Kaplan O: A non-laser light source for photodynamic therapy: in vitro effects on normal and malignant cells. J Med 33: 93-104, 2002.
28. Satonaka H, Kusuzaki K, Matsubara T, Shintani K, Matsumine A and Uchida A: Extracorporeal photodynamic image detection of mouse osteosarcoma in soft tissues utilizing fluorovisualization effect of acridine orange. Oncology 70: 465-473, 2006.
29. Kusuzaki K, Suginoshita T, Minami G, Aomori K, Takeshita H, Murata H, Hashiguchi S, Ashihara T and Hirasawa Y: Fluorovisualization effect of acridine orange on mouse osteosarcoma. Anticancer Res 20: 3019-3024, 2000.
30. Kusuzaki K, Aomori K, Suginoshita T, Minami G, Takeshita H, Murata H, Hashiguchi S, Ashihara T and Hirasawa Y: Total tumor cell elimination with minimum damage to normal tissues in musculoskeletal sarcomas following photodynamic therapy with acridine orange. Oncology 59: 174-180, 2000.
31. Hashiguchi S, Kusuzaki K, Murata H, Takeshita H, Hashiba M, Nishimura T, Ashihara T and Hirasawa Y: Acridine orange excited by low-dose radiation has a strong cytocidal effect on mouse osteosarcoma. Oncology 65: 85-93, 2005.
32. Ryer A: Light measurement handbook. In: Measurement Geometries. Newburyport, International Light, Inc., pp. 29-38, 1998.
33. Kusuzaki K, Minami G, Takeshita H, Murata H, Hashiguchi S, Nozaki T, Ashihara T and Hirasawa Y: Photodynamic inactivation with acridine orange on a multidrug-resistant mouse osteosarcoma cell line. Jpn J Cancer Res 91: 439-445, 2000.
34. Marijnissen JP, Versteeg JA, Star WM and van Putten WL: Tumor and normal response to interstitial photodynamic therapy of the rat R-1 rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 22: 963-972, 1992.
35. LaMuraglia GM, Klyachkin ML, Adili F and Abbott WM: Photodynamic therapy of vein grafts: suppression of intimal hyperplasia of the vein graft but not the anastomosis. J Vasc Surg 21: 882-890, 1995.
36. Beischer AD, Bhathal P, de Steiger R, Penn D and Stylli S: Synovial ablation in a rabbit rheumatoid arthritis model using photodynamic therapy. ANZ J Surg 72: 517-522, 2002.